Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Burk

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Onkologie|October 1, 1990
[Iodo-doxorubicin, a new anthracycline derivative. Current state of progress]K B Mross, T Langenbuch, K Burk, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humansK Mross, U Mayer, K Hamm, et al.
Developmental Psychology|July 9, 2008
Modeling homophily over time with an actor-partner interdependence modelDanielle Popp, Brett Laursen, Margaret Kerr, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumorsK Mross, K Hamm, W Schultze-Seemann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patientsK Mross, U Mayer, T Langenbuch, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|January 15, 2025
Ultrasonic emulsification and aspiration for coral reef atherosclerosis as a novel alternative to transaortic endarterectomy and thoracic aorta-based bypass graftingYamini Vyas, Joshua K Burk, Jane M Chung, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|December 18, 2023
Recurrent symptomatic aortic aneurysm in a young girl with tuberous sclerosis complex and review of the literatureAyman M Alrazim, Joshua K Burk, Travis J Wilder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611. A study by the AIO groups PHASE-I and APOHK Mross, A Hüttmann, K Herbst, et al.
Brain : a Journal of Neurology|October 23, 2003
MRI-based volumetric differentiation of sporadic cerebellar ataxiaK Burk, C Globas, T Wahl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II studyA Harstrick, H J Schmoll, H Wilke, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Onkologie|October 1, 1990
[Iodo-doxorubicin, a new anthracycline derivative. Current state of progress]K B Mross, T Langenbuch, K Burk, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humansK Mross, U Mayer, K Hamm, et al.
Developmental Psychology|July 9, 2008
Modeling homophily over time with an actor-partner interdependence modelDanielle Popp, Brett Laursen, Margaret Kerr, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumorsK Mross, K Hamm, W Schultze-Seemann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patientsK Mross, U Mayer, T Langenbuch, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|January 15, 2025
Ultrasonic emulsification and aspiration for coral reef atherosclerosis as a novel alternative to transaortic endarterectomy and thoracic aorta-based bypass graftingYamini Vyas, Joshua K Burk, Jane M Chung, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|December 18, 2023
Recurrent symptomatic aortic aneurysm in a young girl with tuberous sclerosis complex and review of the literatureAyman M Alrazim, Joshua K Burk, Travis J Wilder, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611. A study by the AIO groups PHASE-I and APOHK Mross, A Hüttmann, K Herbst, et al.
Brain : a Journal of Neurology|October 23, 2003
MRI-based volumetric differentiation of sporadic cerebellar ataxiaK Burk, C Globas, T Wahl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II studyA Harstrick, H J Schmoll, H Wilke, et al.
Pageof 3